Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
Related Questions
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
In what clinical scenarios do you consider pre- or post-treatment with Imiquimod for cutaneous melanoma?
What biopsy/surgical approach do you take for multiple BAPoma lesions in a patient with BAP1 tumor predisposition syndrome?
What is your experience with itraconazole as a primary or adjunct therapy for individuals with numerous BCCs?
What chemoprophylaxis, if any, would you consider in a transplant patient with numerous KC/NMSCs?
What is your preferred treatment for actinic cheilitis?
Do computerized mole-mapping tools play a role in your clinical practice?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
In patients with multiple basal cell carcinoma lesions on vismodegib, would you hold vismodegib while delivering radiation therapy to one locally advanced BCC lesion that was not amenable to surgery?
What are your favorite strategies in fixing post-surgical depressions from facial flaps?
